Immediate-release/extended-release amantadine (OS320) to treat Parkinson’s disease with levodopa-induced dyskinesia: Analysis of the randomized, controlled ALLAY-LID studies

Rascol O, Tönges L, deVries T, Jaros M, Quartel A, Jacobs D; ALLAY-LID I and ALLAY-LID II study groups, Krystkowiak P Parkinsonism and Related Disorders